07/01/2025
8:18 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/17/2025
6:28 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/04/2025
3:32 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/02/2025
5:25 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T | |
05/20/2025
4:58 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
8:58 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2025
4:22 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
8:44 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
4:16 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
6:54 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
6:59 AM | BioMarin Pharmaceutical (Subject)
| Form SC TO-C | |
Get the Latest News and Ratings for BMRN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. |
05/13/2025
10:32 AM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
11:33 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
9:05 AM | BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
8:14 AM | BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/08/2025
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/08/2025
3:12 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2025
6:38 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
8:36 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
6:51 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:53 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:23 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:25 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:17 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:22 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:11 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:15 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:17 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:18 PM | BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:21 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
12:54 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
9:26 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
1:14 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G/A | |
12/03/2024
5:15 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
1:44 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
1:27 PM | BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:01 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
3:50 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad) Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. |
10/01/2024
3:51 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:29 PM | BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
09/24/2024
7:31 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
11:52 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
4:02 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
4:00 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
10:48 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
